News & Analysis on Clinical Trial Services & Contract Research And Development
Specialty pharmaceutical firm Shire has filed for approval to European Regulatory Agencies of SPD476, an ulcerative colitis drug which uses Cosmo's cutting-edge MMX multi matrix system, promising to give the company the upper hand in the $1.6 (€1.34)...
A new laboratory test, which enables the rapid diagnosis of urinary tract infections with novel biosensor technology, has proved so successful that it may replace antiquated testing methods, saving health care costs and valuable diagnosis time.
Outsourcing specialist Celsis Laboratory Group will provide contract testing services for drug firms Mutual and Procter & Gamble, advancing the company's status in this market.
Nanotechnology company Nanotrope has been awarded a $600,000 (€500,000) Small Business Innovation Research (SBIR) Phase 2 grant from NASA for its research in nanoscale droplet technology, which, apart from the agency's deep space initiatives, may have...
According to a new report RFID production is to increase 25-fold in four years, buoyed on by the scramble by pharmaceutical manufacturers to comply with the new RFID Certification program, which aims to synchronise the industry's transition to RFID...
SAFC, a member of the Sigma-Aldrich Group, has launched a supply solutions business, which aims to combine its Specialties business with the manufacturing site that was acquired from Degussa last year. The move is the latest step in Sigma-Aldrich's...